Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: President - Americas of $CTSH Sells 1,728 Shares

Automated

Surya Gummadi, the President - Americas of $CTSH, sold 1,728 shares of the company on 02-02-2026 for an estimated $143,523. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.3% of their shares of this class of stock. Following this trade, they now own 25,641 shares of this class of $CTSH stock.

$CTSH Insider Trading Activity

CTSH Insider Trades

$CTSH insiders have traded $CTSH stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:

  • MICHAEL PATSALOS-FOX has made 0 purchases and 8 sales selling 31,965 shares for an estimated $2,607,417.
  • SURYA GUMMADI (President - Americas) has made 0 purchases and 4 sales selling 22,728 shares for an estimated $1,797,954.
  • JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $806,355.
  • RAVI KUMAR SINGISETTI (Chief Executive Officer) has made 0 purchases and 2 sales selling 6,075 shares for an estimated $500,974.
  • ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 4 sales selling 881 shares for an estimated $65,005.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CTSH Hedge Fund Activity

We have seen 486 institutional investors add shares of $CTSH stock to their portfolio, and 497 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CTSH Revenue

CTSH Quarterly Revenue

$CTSH had revenues of $5.3B in Q4 2025. This is an increase of 4.94% from the same period in the prior year.

You can track CTSH financials on Quiver Quantitative's CTSH stock page.

$CTSH Analyst Ratings

Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • William Blair issued a "Outperform" rating on 11/21/2025
  • Wells Fargo issued a "Overweight" rating on 10/30/2025
  • JP Morgan issued a "Overweight" rating on 10/30/2025
  • Guggenheim issued a "Buy" rating on 10/21/2025

To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.

$CTSH Price Targets

Multiple analysts have issued price targets for $CTSH recently. We have seen 7 analysts offer price targets for $CTSH in the last 6 months, with a median target of $86.0.

Here are some recent targets:

  • Jonathan Lee from Guggenheim set a target price of $100.0 on 01/28/2026
  • Bryan Keane from Citigroup set a target price of $86.0 on 01/22/2026
  • Jason Kupferberg from Wells Fargo set a target price of $98.0 on 01/14/2026
  • Bryan Bergin from TD Cowen set a target price of $84.0 on 01/09/2026
  • Kevin Mcveigh from UBS set a target price of $82.0 on 12/08/2025
  • Daniel R. Perlin from RBC Capital set a target price of $82.0 on 10/30/2025
  • Tien-Tsin Huang from JP Morgan set a target price of $92.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles